Literature DB >> 5128207

Lymphocyte response depressive factor in multiple sclerosis.

E J Field, E A Caspary.   

Abstract

Normal serum contains a lymphocyte response depressive factor and this is more active against the lymphocytes of the blood from which the serum was obtained than against lymphocytes from a different normal blood. The suppressive factor is thus "tailor-made" to its own lymphocytes though cross-reactivity with other lymphocytes does occur. The significance of this is discussed. The suppressive factor has a higher titre in serum from patients with multiple sclerosis or other destructive neurological disease than in normal serum. This may be an instance of a general phenomenon in which lymphocyte sensitization is ordinarily accompanied by production of a suppressor factor able to damp down response so that this is controlled by an "acceleratorbrake" mechanism. The possibilities of imbalance in the pathogenesis of disease and therapeutic manipulation of the level of suppressor substance are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5128207      PMCID: PMC1799818          DOI: 10.1136/bmj.4.5786.529

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

2.  Transformation of human lymphocytes: inhibition by homologous alpha globulin.

Authors:  S R Cooperband; H Bondevik; K Schmid; J A Mannick
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

3.  Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases.

Authors:  D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

4.  Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis.

Authors:  G M Levene; J L Turk; D J Wright; A G Grimble
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

5.  Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor.

Authors:  D E McFarlin; J J Oppenheim
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

6.  Immunological observations in chronic mucocutaneous candidiasis.

Authors:  L Canales; R O Middlemas; J M Louro; M A South
Journal:  Lancet       Date:  1969-09-13       Impact factor: 79.321

7.  Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane.

Authors:  F Paronetto; H Popper
Journal:  N Engl J Med       Date:  1970-08-06       Impact factor: 91.245

8.  Demonstration of sensitized lymphocytes in blood.

Authors:  E J Field; E A Caspary
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

9.  In vitro methods in cell-mediated immunity in man.

Authors:  B R Bloom
Journal:  N Engl J Med       Date:  1971-05-27       Impact factor: 91.245

10.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966
View more
  9 in total

Review 1.  Subacute sclerosing panencephalitis.

Authors:  J H Connolly
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

2.  [Application and significance of macrophage-electrophoretic-mobility-test (MEM) in neurological diseases (author's transl)].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J Günther; H J Gundlach
Journal:  Klin Wochenschr       Date:  1974-05-15

3.  Sphingolipids and their precursors in human brain (normal and MS).

Authors:  B Gerstl; M G Tavaststjerna; L F Eng; J K Smith
Journal:  Z Neurol       Date:  1972

4.  Purification and properties of a lymphocyte inhibition factor from human serum.

Authors:  W H Ford; E A Caspary; B Shenton
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

5.  Letter: Effect of polyunsaturated fatty acids on lymphocyte activity.

Authors:  E J Field; B K Shenton
Journal:  Br Med J       Date:  1973-12-22

6.  Mouse serum factor depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Experientia       Date:  1972-10-15

7.  Serum regulation of in vitro lymphocyte responses in early experimental syphilis.

Authors:  S A Baker-Zander; S Sell; S A Lukehart
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Host resistance in sepsis and trauma.

Authors:  L D MacLean; J L Meakins; K Taguchi; J P Duignan; K S Dhillon; J Gordon
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

9.  The thymus gland: recent studies relating to 'thymosin', ageing and 'slow' infection of the nervous system.

Authors:  E J Field
Journal:  J R Coll Physicians Lond       Date:  1977-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.